Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Plus Therapeutics is a biotechnology business based in the US. Plus Therapeutics stocks (PSTV.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.46 – a decrease of 3.25% over the previous week. Plus Therapeutics employs 17 staff and has a trailing 12-month revenue of around $730,000.
Promoted
National Bank Direct Brokerage
Finder Award
Interactive Brokers
| Latest market close | $3.87 |
|---|---|
| 52-week range | $3.21 - $18.00 |
| 50-day moving average | $4.08 |
| 200-day moving average | $6.25 |
| Wall St. target price | $41.38 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-11.01 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $3.87 from 2023-05-30
| 1 week (2023-05-25) | -5.38% |
|---|---|
| 1 month (2023-05-01) | -3.01% |
| 3 months (2023-03-01) | 1,109.38% |
| 6 months (2022-12-01) | 864.13% |
| 1 year (2022-05-31) | 591.57% |
|---|---|
| 2 years (2021-06-01) | 57.96% |
| 3 years (2020-06-01) | 137.42% |
| 5 years (2018-06-01) | 38.71% |
| Revenue TTM | $730,000 |
|---|---|
| Gross profit TTM | $-9,474,000 |
| Return on assets TTM | -63.84% |
| Return on equity TTM | -242.11% |
| Profit margin | 0% |
| Book value | $1.11 |
| Market capitalisation | $10.4 million |
TTM: trailing 12 months
We're not expecting Plus Therapeutics to pay a dividend over the next 12 months.
Plus Therapeutics's shares were split on a 1:15 basis on 30 April 2023. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Plus Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Plus Therapeutics shares which in turn could have impacted Plus Therapeutics's share price.
Over the last 12 months, Plus Therapeutics's shares have ranged in value from as little as $3.21 up to $18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Plus Therapeutics's is 0.393. This would suggest that Plus Therapeutics's shares are less volatile than average (for this exchange).
Plus Therapeutics, Inc. , a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186Re obisbemeda, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
This guide provides step-by-step instructions on how to buy Coinbase Wrapped Staked ETH, lists some exchanges where you can get it and provides daily price data on (CBETH).
